local_hospital

Emmaues

Address
Liersesteenweg 435, 2800 Mechelen, Belgium

Oncology and Hematologic Malignancies

At Emmaues, cancer research is a major focus, with studies spanning non-small cell lung cancer, small cell lung cancer, breast cancer, colorectal cancer, and several lymphomas and leukemias. The trials are designed to test new treatment options, compare them with current standards, and improve outcomes for patients with advanced or hard-to-treat disease.

  • Non-small cell lung cancer, small cell lung cancer, and lung cancer are central research areas
  • Breast cancer, colorectal cancer, and neuroendocrine tumours are also represented
  • Studies in CLL, SLL, DLBCL, and multiple myeloma explore better treatment effectiveness

Much of the work at this hospital-based research site is aimed at evaluating targeted therapies, immunotherapy combinations, and more effective approaches for patients whose cancers have progressed after earlier treatment.

Respiratory Medicine and Pulmonary Disease

Research in respiratory tract diseases is especially active, covering asthma, COPD, chronic cough, bronchiectasis, and pneumonia. These trials focus on improving symptom control, reducing flare-ups, and finding better long-term options for people living with chronic breathing disorders.

  • Asthma studies include uncontrolled and type 2 inflammatory disease
  • COPD trials aim to lower exacerbations and support better daily function
  • Chronic cough, bronchiectasis, and pneumonia research addresses persistent respiratory symptoms and infection-related illness

The respiratory portfolio at Emmaues also includes work on immune-based therapies, reflecting a broader effort to improve both treatment effectiveness and quality of life.

Cardiovascular, Metabolic, and Kidney-Related Research

Trials in cardiovascular diseases and nutritional and metabolic diseases examine conditions such as atherosclerotic cardiovascular disease, elevated lipoprotein(a), hypertriglyceridemia, obesity, and weight management. There is also research involving chronic kidney disease and systemic inflammation, with the goal of reducing major heart events and improving metabolic health.

  • Cardiovascular disease studies focus on preventing heart attack, stroke, and related complications
  • Lipoprotein(a) and triglyceride research explores new ways to lower lipid-related risk
  • Obesity and weight management trials assess treatments that support healthier body weight

These studies at the AZ Sint Maarten department in Mechelen aim to improve prevention and long-term control of cardiometabolic disease.

Immunology, Infectious Disease, and Vaccination Research

This site also contributes to research on virus diseases, bacterial infections, and immune system phenomena. Trials include studies of influenza, respiratory syncytial virus, human metapneumovirus, urinary tract infections, and COVID-19, along with vaccine studies in healthy adults and older populations.

  • Influenza and RSV vaccine studies evaluate protection and immune response
  • UTI research looks at prevention of E. coli-related infection
  • COVID-19 and other respiratory infection studies assess treatment support and disease control

The research activity here reflects a strong interest in preventing infection, strengthening immune protection, and improving care for common community and seasonal illnesses.

Neurology and Symptom Management

Clinical trials in nervous system diseases at Emmaues include migraine and chronic cough-related symptom burden, with a broader emphasis on easing persistent symptoms that affect daily life. These studies aim to improve control of recurring neurological and airway-related complaints.

  • Chronic migraine and episodic migraine are being studied to reduce attack frequency
  • Refractory and unexplained chronic cough research targets troublesome long-term symptoms
  • Trials focus on better symptom relief and improved patient well-being

By addressing conditions that can be disabling even when not life-threatening, this research supports more practical and patient-centered care.

Digestive, Liver, and Inflammation-Related Research

The site’s work in digestive system diseases includes studies of cirrhosis and other conditions linked to liver damage and fluid balance. Some trials also examine inflammation-related disease processes, reflecting interest in how chronic illness affects multiple organ systems.

  • Cirrhosis of the liver is a key area of investigation
  • Studies evaluate treatments intended to improve disease control and patient stability
  • Immune system and inflammation research connects with broader internal medicine care

These studies add to the broader clinical research profile at the hospital/clinic, where complex chronic diseases are being studied across several specialties.

Site Overview

assignment
77
connected trials
corporate_fare
37
sponsors
science
174
IMPs

Activity Indicator

Last 6 months

8
Trials started
-11% vs previous period.
9
Trials started 6–12 months ago
77
Total trials linked
Highly Active
trending_downDeclining-11%
1
2
2
2
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 15 therapeutic areas and 15 of 174 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 169 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
34
Sponsors (total)
37
Active sponsors
21

Sponsor Network

Top 21 by active trials.

lock +20 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +14 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 307 other sites in Belgium

description
Trial volume
77
Outperforms 93% of sites
public
Therapeutic diversity
16areas
Outperforms 93% of sites
groups
Sponsor diversity
37sponsors
Outperforms 92% of sites

Therapeutic Area Benchmark — Belgium

Select a therapeutic area to compare against other sites in Belgium.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Belgium

Market Share

Country: Belgium

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Emmaues

lock Showing 1 of 77 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include PembrolizumabMerck Sharp & Dohme LLCPhase IIIRecruitingAug 2018

IMP list

lock Showing 1 of 174 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Pembrolizumab8Unknown2018-03-212025-09-18

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.